JENNIFER ANDRES, PHARMD, BCPS

An increase in injection drug use in the United States has augmented the likelihood of acquiring HCV, particularly genotype 3.

Despite the availability of highly active agents against HCV, HIV-infected patients require special considerations for drug interactions when considering treatment options.